Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host vaginal epithelial cell lipids and proteins constitute the complex molecular architecture of the vaginal mucosal surface, serving as the primary interface between the host and the external environment (NIH, 2017). This target encompasses the lipid bilayer of the plasma membrane, including specialized microdomains like lipid rafts, as well as a diverse array of surface proteins such as receptors, adhesion molecules, and transporters (NIH, 2005). Biologically, these components maintain the structural integrity of the vaginal barrier and facilitate interactions with the vaginal microbiota, particularly beneficial Lactobacillus species (ResearchGate, 2023). In the context of disease, this surface is the initial site of attachment and entry for various pathogens, including HIV-1, Candida albicans, and Neisseria gonorrhoeae (PLoS ONE, 2014). Pharmacologically, it is the target for topical agents such as surfactants (e.g., Nonoxynol-9) that disrupt membrane lipids for spermicidal and microbicidal effects (DrugBank). It is also the site of action for polyanionic microbicides that bind to surface proteins to block viral entry (NIH, 2015). However, therapeutic manipulation of this target carries significant safety challenges, as disruption of the epithelial membrane can lead to inflammation and paradoxically increase the risk of infection (PLoS ONE, 2021).
Membrane disruption and competitive binding to surface molecules
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host vaginal epithelial cell lipids and proteins.